1 Schach von Wittenau M, "Whole animal models in safety evaluation" 36 : 177s-182s, 1984
2 Faber MT, "Use of dairy products, lactose, and calcium and risk of ovarian cancer-Results from a Danish case-control study" 51 : 454-464, 2012
3 Wells WW, "The increased severity of atherosclerosis in rabbits on a lactose-containing diet" 68 : 541-549, 1959
4 Petry KG, "The fundamental importance of human galactose metabolism: lessons from genetics and biochemistry" 14 : 98-102, 1998
5 Gueguen L, "The bioavailability of dietary calcium" 19 : 119s-136s, 2000
6 Scrimshaw NS, "The acceptability of milk and milk products in populations with a high prevalence of lactose intolerance" 48 : 1079-1159, 1988
7 Karas-Kuzelicki N, "Synergistic effect of high lactase activity genotype and galactose-1-phosphate uridyl transferase (GALT) mutations on idiopathic presenile cataract formation" 41 : 869-874, 2008
8 Moss M, "Survival trends, coronary event rates, and the MONICA project. Monitoring trends and determinants in cardiovascular disease" 354 : 862-, 1999
9 Sinkeldam EJ, "Subchronic and chronic toxicity/carcinogenicity feeding studies with lactitol in rats" 11 : 165-188, 1992
10 Fraser IS, "Resistant ovary syndrome and premature ovarian failure in young women with galactosaemia" 4 : 133-138, 1986
1 Schach von Wittenau M, "Whole animal models in safety evaluation" 36 : 177s-182s, 1984
2 Faber MT, "Use of dairy products, lactose, and calcium and risk of ovarian cancer-Results from a Danish case-control study" 51 : 454-464, 2012
3 Wells WW, "The increased severity of atherosclerosis in rabbits on a lactose-containing diet" 68 : 541-549, 1959
4 Petry KG, "The fundamental importance of human galactose metabolism: lessons from genetics and biochemistry" 14 : 98-102, 1998
5 Gueguen L, "The bioavailability of dietary calcium" 19 : 119s-136s, 2000
6 Scrimshaw NS, "The acceptability of milk and milk products in populations with a high prevalence of lactose intolerance" 48 : 1079-1159, 1988
7 Karas-Kuzelicki N, "Synergistic effect of high lactase activity genotype and galactose-1-phosphate uridyl transferase (GALT) mutations on idiopathic presenile cataract formation" 41 : 869-874, 2008
8 Moss M, "Survival trends, coronary event rates, and the MONICA project. Monitoring trends and determinants in cardiovascular disease" 354 : 862-, 1999
9 Sinkeldam EJ, "Subchronic and chronic toxicity/carcinogenicity feeding studies with lactitol in rats" 11 : 165-188, 1992
10 Fraser IS, "Resistant ovary syndrome and premature ovarian failure in young women with galactosaemia" 4 : 133-138, 1986
11 Chen YT, "Reduction in oocyte number following prenatal exposure to a diet high in galactose" 214 : 1145-1147, 1981
12 Kushi LH, "Prospective study of diet and ovarian cancer" 149 : 21-31, 1999
13 Seely S, "Possible connection between milk and coronary heart disease: the calcium hypothesis" 54 : 701-703, 2000
14 Seely S, "Possible connection between milk and coronary heart disease: the calcium hypothesis" 54 : 701-703, 2000
15 Forges T, "Pathophysiology of impaired ovarian function in galactosaemia" 12 : 573-584, 2006
16 Lig G, "Ovarian effects of a high lactose diet in the female rat" 45 : 185-192, 2005
17 Strain JJ, "Milk consumption, lactose and copper in the aetiology of ischaemic heart disease" 25 : 99-101, 1988
18 Webb PM, "Milk consumption, galactose metabolism and ovarian cancer (Australia)" 9 : 637-644, 1998
19 Larsson SC, "Milk and lactose intakes and ovarian cancer risk in the Swedish Mammography Cohort" 80 : 1353-1357, 2004
20 Arola H, "Metabolism of lactose in the human body" 202 : 21-25, 1994
21 Stone PM, "Massey LK Effect of dietary and infused lactose on rat intestinal lymph lipids" 31 : 170-178, 1987
22 Vesa TH, "Lactose intolerance" 19 : 165s-175s, 2000
23 Buller HA, "Lactose intolerance" 41 : 141-148, 1990
24 Herrinton LJ, "Lactose and galactose intake and metabolism in relation to the risk of epithelial ovarian cancer" 141 : 407-416, 1995
25 Meloni GF, "Lactose absorption in patients with ovarian cancer" 150 : 183-186, 1999
26 Cramer DW, "Lactase persistence and milk consumption as determinants of ovarian cancer risk" 130 : 904-910, 1989
27 Jyothi M, "Influence of galactose cataract on erythrocytic and lenticular glutathione metabolism in albino rats" 59 : 287-290, 2011
28 Fathalla MF, "Incessant ovulation--a factor in ovarian neoplasia?" 2 : 163-, 1971
29 Segall JJ, "Hypothesis: is lactose a dietary risk factor for ischaemic heart disease?" 37 : 1204-1208, 2008
30 Kaufman FR, "Hypergonadotropic hypogonadism in female patients with galactosemia" 304 : 994-998, 1981
31 Rubio-Gozalbo ME, "Gonadal function in male and female patients with classic galactosemia" 16 : 177-188, 2010
32 Gibson JB, "Gonadal function in galactosemics and in galactose-intoxicated animals" 154 : S14-S20, 1995
33 Koletzko B, "Global standard for the composition of infant formula: recommendations of an ESPGHAN coordinated international expert group" 41 : 584-599, 2005
34 Xu YK, "Galactose metabolism in human ovarian tissue" 25 : 151-155, 1989
35 Liu G, "Galactose metabolism and ovarian toxicity" 14 : 377-384, 2000
36 Swartz WJ, "Galactose inhibition of ovulation in mice" 49 : 522-526, 1988
37 Cooper GS, "Galactose consumption, metabolism, and follicle-stimulating hormone concentrations in women of late reproductive age" 62 : 1168-1175, 1994
38 Cramer DW, "Galactose consumption and metabolism in relation to the risk of ovarian cancer" 2 : 66-71, 1989
39 Fleckenstein A, "Excessive mural calcium overload-a predominant causal factor in the development of stenosing coronary plaques in humans" 4 : 1005-1013, 1990
40 Segall JJ, "Epidemiological evidence for the link between dietary lactose and atherosclerosis, In The Glycation Hypothesis of Atherosclerosis" Champman & Hall 185-, 1997
41 Cramer DW, "Epidemiologic aspects of early menopause and ovarian cancer" 592 : 363-375, 1990
42 Lynch SM, "Effects of copper deficiency on hepatic and cardiac antioxidant enzyme activities in lactose- and sucrose-fed rats" 61 : 345-354, 1989
43 Risch HA, "Dietary lactose intake, lactose intolerance, and the risk of epithelial ovarian cancer in southern Ontario (Canada)" 5 : 540-548, 1994
44 Cramer DW, "Determinants of ovarian cancer risk. II. inferences regarding pathogenesis" 7 : 717-721, 1983
45 Cramer DW, "Determinants of basal follicle-stimulating hormone levels in premenopausal women" 79 : 1105-1109, 1994
46 Ng WG, "Deficit of uridine diphosphate galactose in galactosaemia" 12 : 257-266, 1989
47 Bolton-Smith C, "Coronary heart disease: prevalence and dietary sugars in Scotland" 48 : 119-122, 1994
48 Al-Delaimy WK, "Commentary: Lactose and ischaemic heart disease: a weak 28-year-old hypothesis" 37 : 1214-1216, 2008
49 Til HP, "Chronic (89-week) feeding study with hydroxypropyl distarch phosphate, starch acetate, lactose and sodium alginate in mice" 24 : 825-834, 1986
50 Cramer DW, "Characteristics of women with a family history of ovarian cancer. I. Galactose consumption and metabolism" 74 : 1309-1317, 1994
51 Pomare EW, "Carbohydrate fermentation in the human colon and its relation to acetate concentrations in venous blood" 75 : 1448-1454, 1985
52 Prestoz LL, "Altered follicle stimulating hormone isoforms in female galactosaemia patients" 156 : 116-120, 1997
53 Meyer WR, "Aldose reductase inhibition prevents galactose-induced ovarian dysfunction in the Sprague-Dawley rat" 167 : 1837-1843, 1992
54 Hoverstad T, "Absorption of short-chain fatty acids from the human colon measured by the 14CO2 breath test" 17 : 373-378, 1982
55 Baldrick P, "A toxicological review of lactose to support clinical administration by inhalation" 35 : 719-733, 1997
56 Hodgkinson A, "A comparison of the effects of lactose and of two chemically modified waxy maize starches on mineral metabolism in the rats" 20 : 371-382, 1982
57 Cramer DW, "A case-control study of galactose consumption and metabolism in relation to ovarian cancer" 9 : 95-101, 2000